Brief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
02/11/2023 12:38
Nov 2 (Reuters) - Acer Therapeutics Inc ACER.O :
* LEADING INDEPENDENT PROXY ADVISORY FIRMS ISS AND GLASS
LEWIS
RECOMMEND ACER THERAPEUTICS SHAREHOLDERS VOTE "FOR" THE PROPOSED
MERGER AND RELATED PROPOSALS
Source text for Eikon: ID:nGNX3hsJt2
Further company coverage: ACER.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31